rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-8-19
|
pubmed:abstractText |
Worldwide, prophylactic vaccines against two major human cancers are now commercially available: hepatitis B virus (HBV) vaccines (first licensed in 1982) against primary hepatocellular carcinoma and human papillomavirus (HPV) vaccines (first licensed 2006) against cervical cancer. Initial implementation strategies for HBV vaccination were not successful in preventing disease in the community: it took 15 years for significant global reduction in the burden of this disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1448-5028
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
383-90
|
pubmed:meshHeading |
pubmed-meshheading:20719231-Adolescent,
pubmed-meshheading:20719231-Adult,
pubmed-meshheading:20719231-Carcinoma, Hepatocellular,
pubmed-meshheading:20719231-Child,
pubmed-meshheading:20719231-Cooperative Behavior,
pubmed-meshheading:20719231-Cross-Cultural Comparison,
pubmed-meshheading:20719231-Cross-Sectional Studies,
pubmed-meshheading:20719231-Female,
pubmed-meshheading:20719231-Health Education,
pubmed-meshheading:20719231-Health Plan Implementation,
pubmed-meshheading:20719231-Health Services Accessibility,
pubmed-meshheading:20719231-Health Surveys,
pubmed-meshheading:20719231-Hepatitis B,
pubmed-meshheading:20719231-Hepatitis B Vaccines,
pubmed-meshheading:20719231-Humans,
pubmed-meshheading:20719231-Incidence,
pubmed-meshheading:20719231-Interdisciplinary Communication,
pubmed-meshheading:20719231-Liver Neoplasms,
pubmed-meshheading:20719231-Male,
pubmed-meshheading:20719231-Mass Vaccination,
pubmed-meshheading:20719231-Papillomavirus Infections,
pubmed-meshheading:20719231-Papillomavirus Vaccines,
pubmed-meshheading:20719231-Patient Acceptance of Health Care,
pubmed-meshheading:20719231-Program Evaluation,
pubmed-meshheading:20719231-School Health Services,
pubmed-meshheading:20719231-Sexually Transmitted Diseases, Viral,
pubmed-meshheading:20719231-Uterine Cervical Neoplasms,
pubmed-meshheading:20719231-World Health,
pubmed-meshheading:20719231-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience.
|
pubmed:affiliation |
Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Carlton, Vic. 3053, Australia. margaret.heffernan@rmit.edu.au
|
pubmed:publicationType |
Journal Article,
Comparative Study
|